NON-SMALL CELL LUNG CANCER STAGE III

Clinical trials for NON-SMALL CELL LUNG CANCER STAGE III explained in plain language.

Never miss a new study

Get alerted when new NON-SMALL CELL LUNG CANCER STAGE III trials appear

Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 4 Terminated 1

New hope for lung cancer patients deemed 'Untreatable'

Disease control Terminated

This study tested a three-step treatment for patients with a large, inoperable form of lung cancer who cannot receive the standard therapy. The goal was to see if starting with a drug called durvalumab plus chemotherapy could shrink tumors enough for patients to safely receive fo…

Matched conditions: NON-SMALL CELL LUNG CANCER STAGE III

Phase: PHASE2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

NON-SMALL CELL LUNG CANCER STAGE III

Get alerted when new NON-SMALL CELL LUNG CANCER STAGE III trials appear

New hope for lung cancer patients deemed 'Untreatable'